Alan Fuhrman
Director of Finance/CFO presso TYRA BIOSCIENCES, INC.
Patrimonio netto: 641 115 $ in data 31/03/2024
Profilo
Alan Fuhrman is currently an Independent Director at Esperion Therapeutics, Inc., a Director at Washington Biotechnology & Biomedical Association, a Director at SpringWorks Therapeutics LLC, an Independent Director at Springworks Therapeutics, Inc., and the Chief Financial Officer at Tyra Biosciences, Inc. Previously, he served as an Independent Director at Loxo Oncology, Inc., an Independent Director at Checkmate Pharmaceuticals, Inc., the Chief Financial Officer & Senior Vice President at Sonus Pharmaceuticals, Inc., the Chief Financial Officer at NeoPath, Inc., the Chief Financial Officer & Vice President at Naviscan, Inc., the Chief Financial Officer at Capital Stream, Inc., the President & Chief Operating Officer at Integrex, Inc., the Chief Financial Officer at Medisystems Corp., the CFO & Principal Accounting Officer at Mirna Therapeutics, Inc., the Chief Financial Officer at Amplyx Pharmaceuticals, Inc., and the Chief Financial Officer at Ambit Biosciences Corp.
He obtained his undergraduate degree from Montana State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 25/03/2024 | 10 572 ( 0.01% ) | 520 354 $ | 31/03/2024 | |
| 15/06/2023 | 30 404 ( 0.02% ) | 81 483 $ | 31/03/2024 | |
TYRA BIOSCIENCE, INC
0.00% | 15/03/2024 | 2 395 ( 0.00% ) | 39 278 $ | 31/03/2024 |
Posizioni attive di Alan Fuhrman
| Società | Posizione | Inizio |
|---|---|---|
| SPRINGWORKS THERAPEUTICS, INC. | Director/Board Member | 01/08/2019 |
| ESPERION THERAPEUTICS, INC. | Director/Board Member | 16/03/2020 |
| TYRA BIOSCIENCES, INC. | Director of Finance/CFO | 01/01/2023 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Director/Board Member | 30/08/2019 |
| Washington Biotechnology & Biomedical Association | Director/Board Member | - |
Precedenti posizioni note di Alan Fuhrman
| Società | Posizione | Fine |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Chief Executive Officer | 01/03/2022 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/06/2020 |
| LOXO ONCOLOGY INC | Director/Board Member | 15/02/2019 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Director of Finance/CFO | 01/08/2017 |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Alan Fuhrman
| Montana State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| TYRA BIOSCIENCES, INC. | Health Technology |
| Aziende private | 13 |
|---|---|
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
NeoPath, Inc.
 NeoPath, Inc. Medical SpecialtiesHealth Technology Neopath, Inc. conducts medical diagnosis and automates the interpretation of medical images. AutoPap 300 QC Automatic Pap Screener System is an automated cytology rescreening machine and AutoPap 300 Automatic Pap Screener System is an automated cytology device to screen Pap smear | Health Technology |
Naviscan, Inc.
 Naviscan, Inc. Electronic Production EquipmentElectronic Technology Naviscan, Inc. develops, manufactures, and markets organ molecular imaging scanners. The company was founded by Irving Weinberg on January 31, 2006 and is headquartered in San Diego, CA. | Electronic Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Capital Stream, Inc.
 Capital Stream, Inc. Packaged SoftwareTechnology Services Capital Stream, Inc. provides software and consulting services that enable commercial banks and finance companies to transform paper-based operations into integrated financial supply chains. It also provides data gathering, deal structuring, credit analysis, document generation, booking, account monitoring and ongoing risk management solutions. The company was founded by Clifford J. Monlux and Stan Monlux in 1995 and is headquartered in Seattle, WA. | Technology Services |
Integrex, Inc.
 Integrex, Inc. Electronic Production EquipmentElectronic Technology Integrex, Inc. is a UK-based company that designs and manufactures interactive electronic and IT products for the education, retail, and corporate sectors. The company is based in Bothell, WA. The company's team possesses a diverse range of engineering skills, including mechanical, electrical, and software engineering. The company offers innovative products such as a portable, wire-free interactive projector designed to support individuals living with cognitive challenges. Integrex was acquired by Three-Five Systems, Inc. on February 26, 2004. | Electronic Technology |
| Washington Biotechnology & Biomedical Association | |
Medisystems Corp.
 Medisystems Corp. Medical SpecialtiesHealth Technology Medisystems Corp. manufactures and distributes medical devices for dialysis and blood related treatments. Its products include Streamline and ReadySet blood tubing sets, MasterGuard and ButtonHole needle sets, safety accessories and access management tools. The company was founded on March 22, 1993 and is headquartered in Lawrence, MA. | Health Technology |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Health Technology |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | Commercial Services |
- Borsa valori
- Insiders
- Alan Fuhrman
